• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在单步进程曲线分析中快速评估和参数估计潜在抑制剂的机制:以马丁酰胆碱酯酶为例。

Rapid Mechanistic Evaluation and Parameter Estimation of Putative Inhibitors in a Single-Step Progress-Curve Analysis: The Case of Horse Butyrylcholinesterase.

机构信息

Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazovtrg 2, 1000 Ljubljana, Slovenia.

出版信息

Molecules. 2017 Jul 26;22(8):1248. doi: 10.3390/molecules22081248.

DOI:10.3390/molecules22081248
PMID:28933751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6152194/
Abstract

Highly efficient and rapid lead compound evaluation for estimation of inhibition parameters and type of inhibition is proposed. This is based on a single progress-curve measurement in the presence of each candidate compound, followed by the simultaneous analysis of all of these curves using the ENZO enzyme kinetics suite, which can be implemented as a web application. In the first step, all of the candidate ligands are tested as competitive inhibitors. Where the theoretical curves do not correspond to the experimental data, minimal additional measurements are added, with subsequent processing according to modified reaction mechanisms.

摘要

提出了一种高效快速的先导化合物评估方法,用于估计抑制参数和抑制类型。该方法基于在每个候选化合物存在的情况下进行单次进展曲线测量,然后使用 ENZO 酶动力学套件同时分析所有这些曲线,该套件可以作为网络应用程序实现。在第一步中,所有候选配体均被测试为竞争性抑制剂。如果理论曲线与实验数据不对应,则会添加最小的附加测量值,并根据修改后的反应机制进行后续处理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b082/6152194/60ee2b06db0f/molecules-22-01248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b082/6152194/847489d4f498/molecules-22-01248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b082/6152194/85ad05418570/molecules-22-01248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b082/6152194/60ee2b06db0f/molecules-22-01248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b082/6152194/847489d4f498/molecules-22-01248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b082/6152194/85ad05418570/molecules-22-01248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b082/6152194/60ee2b06db0f/molecules-22-01248-g003.jpg

相似文献

1
Rapid Mechanistic Evaluation and Parameter Estimation of Putative Inhibitors in a Single-Step Progress-Curve Analysis: The Case of Horse Butyrylcholinesterase.在单步进程曲线分析中快速评估和参数估计潜在抑制剂的机制:以马丁酰胆碱酯酶为例。
Molecules. 2017 Jul 26;22(8):1248. doi: 10.3390/molecules22081248.
2
Mechanism of eserine action on the hydrolysis of butyrylthiocholine by butyrylcholinesterase.毒扁豆碱对丁酰胆碱酯酶水解丁酰硫代胆碱作用的机制。
J Enzyme Inhib. 1997 Jan;11(3):199-208. doi: 10.3109/14756369709027650.
3
Microcalorimetric study of the inhibition of butyrylcholinesterase by paraoxon.对氧磷对丁酰胆碱酯酶抑制作用的微量量热法研究
Anal Biochem. 2009 Jun 15;389(2):97-101. doi: 10.1016/j.ab.2009.03.041. Epub 2009 Mar 31.
4
Inhibition of butyrylcholinesterase by phenothiazine derivatives.
J Enzyme Inhib Med Chem. 2002 Jun;17(3):197-202. doi: 10.1080/1475636021000003165.
5
Catalytic parameters for the hydrolysis of butyrylthiocholine by human serum butyrylcholinesterase variants.人血清丁酰胆碱酯酶变体催化丁酰硫代胆碱水解的催化参数。
Chem Biol Interact. 1999 May 14;119-120:165-71. doi: 10.1016/s0009-2797(99)00025-3.
6
Horse serum butyrylcholinesterase kinetics: a molecular mechanism based on inhibition studies with dansylaminoethyltrimethylammonium.马血清丁酰胆碱酯酶动力学:基于对丹磺酰氨基乙基三甲基铵抑制研究的分子机制
Biochem Cell Biol. 1987 Jun;65(6):529-35. doi: 10.1139/o87-068.
7
[Inhibition of catalytic activity of butyrylcholinesterase from the horse serum by high concentrations of N-methyl-N-(beta-acetoxyethyl)-piperidinium substrate].
Zh Evol Biokhim Fiziol. 2005 Jul-Aug;41(4):339-42.
8
Comparative effects of cationic triarylmethane, phenoxazine and phenothiazine dyes on horse serum butyrylcholinesterase.阳离子三芳基甲烷、吩恶嗪和吩噻嗪染料对马血清丁酰胆碱酯酶的比较作用。
Arch Biochem Biophys. 2008 Oct 15;478(2):201-5. doi: 10.1016/j.abb.2008.07.006. Epub 2008 Jul 16.
9
A step toward the reactivation of aged cholinesterases--crystal structure of ligands binding to aged human butyrylcholinesterase.向着老化乙酰胆碱酯酶复活迈出的一步——结合老化人丁酰胆碱酯酶的配体的晶体结构。
Chem Biol Interact. 2013 Mar 25;203(1):19-23. doi: 10.1016/j.cbi.2012.08.005. Epub 2012 Aug 16.
10
New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter.丁酰胆碱酯酶活性测定的新见解:血清稀释因子作为关键参数
PLoS One. 2015 Oct 7;10(10):e0139480. doi: 10.1371/journal.pone.0139480. eCollection 2015.

引用本文的文献

1
Kinetic Modeling of Time-Dependent Enzyme Inhibition by Pre-Steady-State Analysis of Progress Curves: The Case Study of the Anti-Alzheimer's Drug Galantamine.基于稳态前分析的时变酶抑制的动力学建模:以抗阿尔茨海默病药物加兰他敏为例。
Int J Mol Sci. 2022 May 3;23(9):5072. doi: 10.3390/ijms23095072.
2
The Removal of Time-Concentration Data Points from Progress Curves Improves the Determination of : The Example of Paraoxonase 1.从进度曲线中删除时间-浓度数据点可改善:对 paraoxonase 1 的研究示例。
Molecules. 2022 Feb 15;27(4):1306. doi: 10.3390/molecules27041306.
3
Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes.

本文引用的文献

1
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.体内活性可逆丁酰胆碱酯酶抑制剂的研制。
Sci Rep. 2016 Dec 21;6:39495. doi: 10.1038/srep39495.
2
Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.阿尔茨海默病中的胆碱酯酶抑制剂疗法:灵长类动物中不可逆的中枢神经系统选择性乙酰胆碱酯酶抑制的局限性和耐受性
J Alzheimers Dis. 2017;55(3):1285-1294. doi: 10.3233/JAD-160733.
3
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.
开发强效、可逆、选择性丁酰胆碱酯酶抑制剂作为荧光探针。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):498-505. doi: 10.1080/14756366.2019.1710502.
4
New Sesquiterpenoids from the Fermented Broth of and their Anti-Acetylcholinesterase Activity.发酵液中 的新倍半萜及其乙酰胆碱酯酶抑制活性。
Molecules. 2019 Aug 16;24(16):2980. doi: 10.3390/molecules24162980.
新型他克林-苯并呋喃杂合体作为治疗阿尔茨海默病的强效多靶点导向配体:设计、合成、生物学评价和 X 射线晶体学。
J Med Chem. 2016 Jan 14;59(1):114-31. doi: 10.1021/acs.jmedchem.5b01119. Epub 2015 Dec 29.
4
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.一种新型纳摩尔级选择性丁酰胆碱酯酶抑制剂的发现、生物学评价及晶体结构
J Med Chem. 2014 Oct 9;57(19):8167-79. doi: 10.1021/jm501195e. Epub 2014 Sep 29.
5
Novel selective and irreversible mosquito acetylcholinesterase inhibitors for controlling malaria and other mosquito-borne diseases.新型选择性和不可逆的蚊子乙酰胆碱酯酶抑制剂,用于控制疟疾和其他蚊媒疾病。
Sci Rep. 2013;3:1068. doi: 10.1038/srep01068. Epub 2013 Jan 15.
6
The significance of low substrate concentration measurements for mechanistic interpretation in cholinesterases.低底物浓度测量在胆碱酯酶中的机制解释中的意义。
Chem Biol Interact. 2013 Mar 25;203(1):44-50. doi: 10.1016/j.cbi.2012.12.005. Epub 2012 Dec 29.
7
The integrated Michaelis-Menten rate equation: déjà vu or vu jàdé?整合的米氏方程:似曾相识还是似曾相识?
J Enzyme Inhib Med Chem. 2013 Aug;28(4):879-93. doi: 10.3109/14756366.2012.688039. Epub 2012 May 28.
8
ENZO: a web tool for derivation and evaluation of kinetic models of enzyme catalyzed reactions.ENZO:一个用于推导和评估酶催化反应动力学模型的网络工具。
PLoS One. 2011;6(7):e22265. doi: 10.1371/journal.pone.0022265. Epub 2011 Jul 19.
9
X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger.人丁酰胆碱酯酶 G117H 突变体中反应中间体的 X 射线晶体学快照,该突变体是一种神经毒剂靶标,被工程化为催化型生物清除剂。
Biochem J. 2011 Feb 15;434(1):73-82. doi: 10.1042/BJ20101648.
10
Application of the Van Slyke-Cullen irreversible mechanism in the analysis of enzymatic progress curves.范斯莱克-卡伦不可逆机制在酶促反应进程曲线分析中的应用。
Anal Biochem. 2009 Nov 15;394(2):287-9. doi: 10.1016/j.ab.2009.06.040. Epub 2009 Jul 21.